PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

Clinical trial NCT06967272 · RECRUITING

Trial details

NCT number: NCT06967272
Sponsor: Sinovac Life Sciences Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rotavirus Gastroenteritis

Start date: 2025-01-20
Primary completion: 2026-06-15
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.